Is TaperAid Safe? FDA Warning Letter Review (2018)
Compiled by the Supplement Safety Data Team | Sourced from Official FDA Records on January 11, 2018
Executive Summary
The FDA issued a warning letter to TaperAid on January 11, 2018 citing regulatory violations. The letter was issued by Center for Food Safety and Applied Nutrition.
Detailed Analysis
False Claims and Regulatory Violations
The FDA identified regulatory violations in TaperAid's operations or product claims.
Potential Health Risks
DEPARTMENT OF HEALTHAND HUMAN SERVICESFOOD AND DRUG ADMINISTRATIONSILVER SPRING, MD 20993
Regulatory Context
“People using short acting opioids (which includes many pain management medications and heroin) will notice a significant lowering of tolerance to their opiate of choice.”
“What is the report on painkillers? People using short acting opioids such as hydrocodone, percoset, oxycontin, morphine, etc. have reported a significant decrease in intake as well as the ability to jump off with TaperAid Complete.”
Key Entities Identified
Frequently Asked Questions
- What did the FDA find wrong with TaperAid?
- The FDA issued a warning letter citing regulatory violations related to their products or manufacturing practices.
- Are TaperAid products safe to use?
- Based on the FDA's findings, consumers should exercise caution. The company was found to have regulatory issues that may affect product safety.
- What should I do if I've used TaperAid products?
- If you have used products from TaperAid and experience any adverse effects, contact your healthcare provider immediately. You can also report adverse events to the FDA's MedWatch program.
Source Document
This report is based on an official FDA warning letter. The original document is a public record.
View Original FDA Warning Letter